Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent β-thalassaemia

Ali T. TaherVip ViprakasitMaria Domenica CappelliniDominik KrausPatrick CechDietmar VolzErica WinterStephane NaveJuergen DukartOmar KhwajaAnnette KoernerRicardo HermosillaCarlo BrugnaraAmerican University of Beirut Medical CenterChildren's Hospital BostonUniversità degli Studi di MilanoHeinrich-Heine-Universität DüsseldorfMahidol UniversityF. Hoffmann-La Roche AGForschungszentrum Jülich (FZJ)Harvard Medical SchoolRoche Innovation Center New York2022-08-042022-08-042021-07-01British Journal of Haematology. Vol.194, No.2 (2021), 474-47713652141000710482-s2.0-85105232948https://repository.li.mahidol.ac.th/handle/20.500.14594/78098Mahidol UniversityMedicineHaematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent β-thalassaemiaLetterSCOPUS10.1111/bjh.17479